It is no exaggeration to say that electronic data capture (EDC) is a practice of the new millennium; the introduction of technology into the collection and cleaning of clinical trial data has gained real momentum since 2000. Quintiles has embarked on 300 studies facilitating EDC since the turn of the century; 130 of these have since been locked. While early EDC studies were small and generally limited to Phase I and II trials, today 48 percent of these studies are in Phase III, a figure which demonstrates the confidence now placed in EDC. In total, Quintiles has run EDC at more than 19,000 trial sites worldwide, covering more than 310,000 subjects.